Ranbaxy arm launches Losartan in Malaysia

Ranbaxy Laboratories’ subsidiary Ranbaxy Malaysia Sdn Bhd has made the day-one-launch of generic Losartan K, 50mg and 100 mg tablets in Malaysia.

The company obtained necessary approval from the Drug Control Authority in Malaysia to manufacture and market the product locally.

The market size of Losartan K tablets in Malaysia is $6.29 million. The product will be marketed under the brand name of Covance Tablets are indicated and employed as an antihypertensive.

Ranbaxy’s plant in Malaysia has developed this dosage form through the transfer of scientific skills and technology from its R&D center, located in Gurgaon in India. The product will be manufactured at its facility in Malaysia.

Headquartered in India, Ranbaxy Laboratories is an integrated, research based, international pharmaceutical company that produces a wide range of generic medicines.